Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 13
2021 17
2022 22
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 Infection and COVID-19 in Children.
Waghmare A, Hijano DR. Waghmare A, et al. Clin Chest Med. 2023 Jun;44(2):359-371. doi: 10.1016/j.ccm.2022.11.014. Epub 2022 Nov 22. Clin Chest Med. 2023. PMID: 37085225 Free PMC article. Review.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is common in children, and clinical manifestations can vary depending on age, underlying disease, and vaccination status. ...
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is common in children, and clinical manifestatio …
Mucormycosis and COVID-19: An epidemic within a pandemic in India.
Selarka L, Sharma S, Saini D, Sharma S, Batra A, Waghmare VT, Dileep P, Patel S, Shah M, Parikh T, Darji P, Patel A, Goswami G, Shah A, Shah S, Lathiya H, Shah M, Sharma P, Chopra S, Gupta A, Jain N, Khan E, Sharma VK, Sharma AK, Chan ACY, Ong JJY. Selarka L, et al. Among authors: waghmare vt. Mycoses. 2021 Oct;64(10):1253-1260. doi: 10.1111/myc.13353. Epub 2021 Jul 24. Mycoses. 2021. PMID: 34255907 Free PMC article.
IMPORTANCE: Coronavirus disease (COVID-19) causes an immunosuppressed state and increases risk of secondary infections like mucormycosis. ...RESULTS: Of the 2567 COVID-19 patients admitted to 3 tertiary centres, 47 (1.8%) were diagnosed with mucormycos …
IMPORTANCE: Coronavirus disease (COVID-19) causes an immunosuppressed state and increases risk of secondary infections like mu …
Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir.
Ford ES, Simmons W, Karmarkar EN, Yoke LH, Braimah AB, Orozco JJ, Ghiuzeli CM, Barnhill S, Sack CL, Benditt JO, Roychoudhury P, Greninger AL, Shapiro AE, Hammond JL, Rusnak JM, Dolsten M, Boeckh M, Liu C, Cheng GS, Corey L. Ford ES, et al. Among authors: boeckh m. Clin Infect Dis. 2023 Mar 4;76(5):926-929. doi: 10.1093/cid/ciac868. Clin Infect Dis. 2023. PMID: 36326680 Free PMC article.
A patient with B-cell acute lymphoblastic leukemia (ALL) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had persistent, progressive pneumonia with viremia after 5 months of infection despite monoclonal antibodies, intravenous (IV) remdesivir …
A patient with B-cell acute lymphoblastic leukemia (ALL) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 …
Clinical Profile of SARS-CoV-2-Infected Neonates.
Kulkarni RK, Valvi C, Dawre R, Rajput U, Nagpal R, Deshmukh I, Kamath P, Harwani R, Srinivasarangan R, Sonteke S, R A, Kamble S, Naik S, Bhosale R, Waghmare R, Modi D, Gajbhiye R, Kinikar AA. Kulkarni RK, et al. Among authors: waghmare r. Cureus. 2022 Jun 24;14(6):e26298. doi: 10.7759/cureus.26298. eCollection 2022 Jun. Cureus. 2022. PMID: 35898362 Free PMC article.
Background There are conflicting data on the mother-to-child transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and few studies have described the clinical course of neonates infected with SARS-CoV-2. Objectives …
Background There are conflicting data on the mother-to-child transmission of severe acute respiratory syndrome coronavirus 2 (SARS- …
Sphingolipids: Effectors and Achilles Heals in Viral Infections?
Schneider-Schaulies S, Schumacher F, Wigger D, Schöl M, Waghmare T, Schlegel J, Seibel J, Kleuser B. Schneider-Schaulies S, et al. Among authors: waghmare t. Cells. 2021 Aug 24;10(9):2175. doi: 10.3390/cells10092175. Cells. 2021. PMID: 34571822 Free PMC article. Review.
Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
Doll MK, Waghmare A, Heit A, Levenson Shakoor B, Kimball LE, Ozbek N, Blazevic RL, Mose L, Boonyaratanakornkit J, Stevens-Ayers TL, Cornell K, Sheppard BD, Hampson E, Sharmin F, Goodwin B, Dan JM, Archie T, O'Connor T, Heckerman D, Schmitz F, Boeckh M, Crotty S. Doll MK, et al. Among authors: boeckh m, waghmare a. JAMA Netw Open. 2023 Feb 1;6(2):e231181. doi: 10.1001/jamanetworkopen.2023.1181. JAMA Netw Open. 2023. PMID: 36853602 Free PMC article.
OBJECTIVES: To examine COVID-19 acute and postacute clinical outcomes among a well-characterized cohort of unvaccinated and previously uninfected adults who contracted SARS-CoV-2 during the Omicron (BA.1/BA.2) surge, and to compare outcomes with …
OBJECTIVES: To examine COVID-19 acute and postacute clinical outcomes among a well-characterized cohort of unvaccinated and pr …
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections.
Boonyaratanakornkit J, Boeckh M, Waghmare A. Boonyaratanakornkit J, et al. Among authors: boeckh m, waghmare a. Curr Opin Infect Dis. 2022 Aug 1;35(4):280-287. doi: 10.1097/QCO.0000000000000846. Epub 2022 Jul 5. Curr Opin Infect Dis. 2022. PMID: 35849517 Review.
Several novel mAbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have received emergency use authorization by the Food and Drug Administration (FDA) for the early treatment of mild to moderate COVID-19. ...Novel mAbs are a …
Several novel mAbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have received emergency use aut …
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.
Ogimi C, Qu P, Boeckh M, Bender Ignacio RA, Zangeneh SZ. Ogimi C, et al. Among authors: boeckh m. Epidemiol Infect. 2021 Mar 16;149:e75. doi: 10.1017/S0950268821000571. Epidemiol Infect. 2021. PMID: 33722335 Free PMC article.
The magnitude of association between BCG coverage and COVID-19 death rate varied according to HAQI, and MCV coverage had little effect on the association between BCG and COVID-19 deaths. While there are associations between live vaccine coverage and …
The magnitude of association between BCG coverage and COVID-19 death rate varied according to HAQI, and MCV coverage had littl …
Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naive Adults During Delta Versus Omicron Waves.
Doll MK, Waghmare A, Heit A, Levenson Shakoor B, Kimball LE, Ozbek N, Blazevic RL, Mose L, Boonyaratanakornkit J, Stevens-Ayers TL, Cornell K, Sheppard BD, Hampson E, Sharmin F, Goodwin B, Dan JM, Archie T, O'Connor T, Heckerman D, Schmitz F, Boeckh M, Crotty S. Doll MK, et al. Among authors: boeckh m, waghmare a. medRxiv [Preprint]. 2022 Nov 14:2022.11.13.22282222. doi: 10.1101/2022.11.13.22282222. medRxiv. 2022. PMID: 36425923 Free PMC article. Updated. Preprint.
OBJECTIVE: To examine COVID-19 acute and post-acute clinical outcomes among a well-characterized cohort of unvaccinated and previously uninfected adults who contracted SARS-CoV-2 during the Omicron (BA.1/BA.2) surge, and to compare outcomes with …
OBJECTIVE: To examine COVID-19 acute and post-acute clinical outcomes among a well-characterized cohort of unvaccinated and pr …
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology.
Khawaja F, Papanicolaou G, Dadwal S, Pergam SA, Wingard JR, Boghdadly ZE, Abidi MZ, Waghmare A, Shahid Z, Michaels L, Hill JA, Kamboj M, Boeckh M, Auletta JJ, Chemaly RF. Khawaja F, et al. Among authors: boeckh m, waghmare a. Transplant Cell Ther. 2023 Jan;29(1):10-18. doi: 10.1016/j.jtct.2022.10.010. Epub 2022 Oct 21. Transplant Cell Ther. 2023. PMID: 36273782 Free PMC article.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), disproportionately affects immunocompromised and elderly patients. ...Optimizing the use, timing, and number of doses of the COVID …
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 …
60 results